EXPRESSION OF THE D-2 SUBFAMILY OF DOPAMINE-RECEPTOR GENES IN KIDNEY

被引:63
|
作者
GAO, DQ
CANESSA, LM
MOURADIAN, MM
JOSE, PA
机构
[1] GEORGETOWN UNIV,MED CTR,WASHINGTON,DC 20007
[2] NINCDS,EXPTL THERAPEUT BRANCH,BETHESDA,MD 20892
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 266卷 / 04期
关键词
D-2-LIKE DOPAMINE RECEPTORS; HYPERTENSION; GLOMERULI;
D O I
10.1152/ajprenal.1994.266.4.F646
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The D-2, D-3, and D-4 dopamine receptors cloned from brain correspond to the classically described ''D-2'' receptors. Although radioligand binding and biochemical and functional studies have demonstrated the presence of D-2-like receptors in the kidney, the expression of D-2, D-3, or D-4 receptor genes has not been conclusively demonstrated in the kidney. Since Northern blot analysis may have precluded demonstration of dopamine receptor mRNAs because of their relative low abundance, the expression of the D-2long and D-3 receptor genes was studied by reverse transcription-polymerase chain reaction (RT-PCR). We were able to amplify PCR products of the predicted size using mRNA from glomeruli, proximal tubules, outer medulla, inner medulla, and renal microvessels from normotensive Wistar-Kyoto rats (WKY). Specificities of the amplified products were confirmed by restriction analysis and by sequencing the D-2long product and Southern blotting the D-3 product. Because some studies have suggested that D-2-like receptor actions may be different between WKY and spontaneously hypertensive rats (SHR), similar studies were performed in this rat strain. In the SHR, as in WKY, PCR products of the predicted size were amplified, and restriction enzyme digestion patterns were as predicted from the cDNA sequence. The PCR-generated cDNA from the glomeruli of SHR was subcloned and sequenced and was revealed to be identical to the D-2long receptor cDNA from WKY. We conclude that the D-2long and D-3 receptor genes are expressed in specific regions of the kidney including the glomeruli. No differences in the sequence of the D-2long receptor cDNA in part of the 3rd cytoplasmic loop were noted between WKY and SHR. These studies do not rule out the possibility that mutations in other segments of the receptor exist in the SHR.
引用
收藏
页码:F646 / F650
页数:5
相关论文
共 50 条
  • [1] ALLOSTERIC REGULATION OF THE RAT D-2 DOPAMINE-RECEPTOR
    HOARE, SRJ
    STRANGE, PG
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) : S92 - S92
  • [2] DETERMINANTS OF LIGAND-BINDING AT THE D-2 DOPAMINE-RECEPTOR
    NAYLOR, L
    WOODWARD, R
    DANIELL, S
    COLEY, C
    STRANGE, P
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) : 87 - 91
  • [3] DECREASED EXPRESSION OF THE 2 D-2 DOPAMINE-RECEPTOR ISOFORMS IN BROMOCRIPTINE-RESISTANT PROLACTINOMAS
    CACCAVELLI, L
    FERON, F
    MORANGE, I
    ROUER, E
    BENAROUS, R
    DEWAILLY, D
    JAQUET, P
    KORDON, C
    ENJALBERT, A
    NEUROENDOCRINOLOGY, 1994, 60 (03) : 314 - 322
  • [4] D-2 DOPAMINE-RECEPTOR ANTISENSE OLIGODEOXYNUCLEOTIDE INHIBITS THE SYNTHESIS OF A FUNCTIONAL POOL OF D-2 DOPAMINE-RECEPTORS
    QIN, ZH
    ZHOU, LW
    ZHANG, SP
    WANG, YM
    WEISS, B
    MOLECULAR PHARMACOLOGY, 1995, 48 (04) : 730 - 737
  • [5] STUDIES ON A CHIMERIC RAT D-2 D-3 DOPAMINE-RECEPTOR
    NORMAN, DA
    NAYLOR, LH
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (02) : S143 - S143
  • [6] CHARACTERIZATION OF AN EPITOPE-TAGGED FORM OF THE D-2 DOPAMINE-RECEPTOR
    SANDERSON, EM
    STRANGE, PG
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 : P102 - P102
  • [7] ALLOSTERIC REGULATION OF THE RAT D-2 DOPAMINE-RECEPTOR BY AMILORIDE ANALOGS
    HOARE, S
    STRANGE, PG
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U60 - U60
  • [8] IN-VIVO ADMINISTRATION OF AN OLIGODEOXYNUCLEOTIDE ANTISENSE TO THE D-2 DOPAMINE-RECEPTOR MESSENGER-RNA INHIBITS D-2 DOPAMINE RECEPTOR-MEDIATED BEHAVIOR AND THE EXPRESSION OF D-2 DOPAMINE-RECEPTORS IN MOUSE STRIATUM
    ZHOU, LW
    ZHANG, SP
    QIN, ZH
    WEISS, B
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (02): : 1015 - 1023
  • [9] ON THE D-1 AND D-2 DOPAMINE-RECEPTOR PARTICIPATION IN LEARNING AND MEMORY IN MICE
    VERMA, A
    KULKARNI, SK
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1993, 15 (09): : 597 - 607
  • [10] BROMOCRIPTINE IN THE TREATMENT OF ALCOHOLICS WITH THE D-2 DOPAMINE-RECEPTOR A1 ALLELE
    LAWFORD, BR
    YOUNG, RM
    ROWELL, JA
    QUALICHEFSKI, J
    FLETCHER, BH
    SYNDULKO, K
    RITCHIE, T
    NOBLE, EP
    NATURE MEDICINE, 1995, 1 (04) : 337 - 341